Immediate Impact
2 from Science/Nature 61 standout
Citing Papers
Cross-priming in cancer immunology and immunotherapy
2025 Standout
Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
2025 Standout
Works of Peter Koelblinger being referenced
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
2021
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Koelblinger | 250 | 250 | 87 | 35 | 443 | |
| Tianyu Wang | 297 | 183 | 124 | 32 | 512 | |
| Michelle S. Miller | 148 | 276 | 76 | 27 | 501 | |
| Jeffrey Johnson | 178 | 203 | 45 | 29 | 390 | |
| Andrea Boutros | 324 | 169 | 120 | 30 | 503 | |
| R. Gonzalez | 258 | 268 | 76 | 42 | 449 | |
| Malini Guha | 197 | 286 | 69 | 20 | 451 | |
| Angela Hu | 132 | 246 | 77 | 19 | 437 | |
| Jarkko Koivunen | 144 | 255 | 65 | 25 | 437 | |
| Janice M. Mehnert | 181 | 299 | 51 | 23 | 399 | |
| Yin Gu | 134 | 206 | 162 | 23 | 472 |
All Works
Login with ORCID to disown or claim papers
Loading papers...